Last reviewed · How we verify
Pelvic inflammatory disease due to Mycoplasma hominis
Approved treatments
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pelvic inflammatory disease due to Mycoplasma hominis patent landscape — cliff calendar, originator estates, attackable patents
- Pelvic inflammatory disease due to Mycoplasma hominis treatment landscape brief
- Pelvic inflammatory disease due to Mycoplasma hominis treatment updates RSS
Frequently asked questions about Pelvic inflammatory disease due to Mycoplasma hominis
What drugs treat Pelvic inflammatory disease due to Mycoplasma hominis?
Tracked treatments include Zithromax.
What is the treatment for Pelvic inflammatory disease due to Mycoplasma hominis?
Standard treatment for Pelvic inflammatory disease due to Mycoplasma hominis includes Zithromax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pelvic inflammatory disease due to Mycoplasma hominis patent cliff · Pelvic inflammatory disease due to Mycoplasma hominis CI report
- Treatment: Zithromax · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing